Role of matrix metalloproteinase-9 in the development of diabetic retinopathy and its regulation by H-Ras.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Investigative Ophthalmology and Visual Science

• Publication date

  2010-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1167/iovs.09-4851PMID 20220057PMCID PMC2910650
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Simvastatin protects diabetic rats against kidney injury through the suppression of renal matrix metalloproteinase-9 expression.

  2010cited by this paper
• Matrix metalloproteinases.

  2010cited by this paper
• Metabolic memory in diabetes - from in vitro oddity to in vivo problem: role of apoptosis.

  2010cited by this paper
• Simvastatin protects diabetic rats against kidney injury through the suppression of renal matrix metalloproteinase-9 expression

  2010cited by this paper
• Translocation of H-Ras and its implications in the development of diabetic retinopathy.

  2009cited by this paper
• TNF-α mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations

  2009cited by this paper
• Neutrophil elastase activity compensates for a genetic lack of matrix metalloproteinase‐9 (MMP‐9) in leukocyte infiltration in a model of experimental peritonitis

  2009cited by this paper
• Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy

  2009cited by this paper
• Simvastatin and lovastatin inhibit breast cell invasion induced by H-Ras.

  2009cited by this paper
• Oxidative stress and the development of diabetic retinopathy: contributory role of matrix metalloproteinase-2.

  2009cited by this paper
• Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy.

  2008cited by this paper
• Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy.

  2008cited by this paper
• Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia.

  2008cited by this paper
• Role of the hemopexin domain of matrix metalloproteinases in cell migration

  2008cited by this paper
• Diabetes regulates small molecular weight G-protein, H-Ras, in the microvasculature of the retina: implication in the development of retinopathy.

  2008cited by this paper
• Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy

  2008cited by this paper
• The Relationship Between Plasma MMP-9 and TIMP-2 Levels and Intraocular Pressure Elevation in Diabetic Patients After Intravitreal Triamcinolone Injection

  2008cited by this paper
• Role of the polyol pathway in high glucose-induced apoptosis of retinal pericytes and proliferation of endothelial cells.

  2008cited by this paper
• Filamin A-mediated Down-regulation of the Exchange Factor Ras-GRF1 Correlates with Decreased Matrix Metalloproteinase-9 Expression in Human Melanoma Cells*

  2007influential reference
• Statins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activation.

  2007cited by this paper
• Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue.

  2007cited by this paper
• Proteolytic Degradation of VE-Cadherin Alters the Blood-Retinal Barrier in Diabetes

  2007cited by this paper
• Small molecular weight G-protein, H-Ras, and retinal endothelial cell apoptosis in diabetes

  2007cited by this paper
• Ras as a therapeutic target in hematologic malignancies

  2007cited by this paper
• Matrix Metalloproteinase‐2 Expression and Apoptogenic Activity in Retinal Pericytes

  2007cited by this paper
• Deregulated Ras signaling in developmental disorders: new tricks for an old dog.

  2007cited by this paper
• H‐Ras selectively up‐regulates MMP‐9 and COX‐2 through activation of ERK1/2 and NF‐κB: An implication for invasive phenotype in rat liver epithelial cells

  2006cited by this paper
• Matrix metalloproteinases (MMPs) in health and disease: an overview.

  2006cited by this paper
• Zinc induces ERK-dependent cell death through a specific Ras isoform

  2006cited by this paper
• Isoginkgetin inhibits tumor cell invasion by regulating phosphatidylinositol 3-kinase/Akt–dependent matrix metalloproteinase-9 expression

  2006cited by this paper
• Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood–retinal barrier

  2005cited by this paper
• Farnesyltransferase inhibitor SCH‐66336 downregulates secretion of matrix proteinases and inhibits carcinoma cell migration

  2005cited by this paper
• Role of Nitric Oxide in Matrix Remodeling in Diabetes and Heart Failure

  2004cited by this paper
• Potential contributory role of H-Ras, a small G-protein, in the development of retinopathy in diabetic rats.

  2004cited by this paper
• Simvastatin inhibits leukocyte accumulation and vascular permeability in the retinas of rats with streptozotocin-induced diabetes.

  2004cited by this paper
• Diabetes-induced mitochondrial dysfunction in the retina.

  2003cited by this paper
• Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9)

  2002cited by this paper
• MATRIX METALLOPROTEINASES IN HUMAN DIABETIC AND NONDIABETIC VITREOUS

  2001cited by this paper
• Targeted Genomic Disruption of H-ras and N-ras, Individually or in Combination, Reveals the Dispensability of Both Loci for Mouse Growth and Development

  2001cited by this paper
• Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.

  2000cited by this paper
• Tissue inhibitors of metalloproteinases: evolution, structure and function.

  2000cited by this paper
• Human diabetic neovascular membranes contain high levels of urokinase and metalloproteinase enzymes.

  1999cited by this paper
• Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor.

  1999cited by this paper
• Matrix Metalloproteinases*

  1999cited by this paper
• Overview of matrix metalloproteinase expression in cultured human cells.

  1998cited by this paper
• Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.

  1998cited by this paper
• Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy.

  1996cited by this paper
• Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes

  1995cited by this paper

• Theophylline Inhibits Capillary Degeneration in Early Diabetic Retinopathy

  2026cites this paper
• Molecular stress and neurovascular injury in the diabetic retina.

  2026cites this paper
• A theoretical framework for extrapolating Andrographis paniculata mechanisms to the novel CIRDD and IROD diabetes clusters

  2026cites this paper
• Integration of network pharmacology, molecular docking and pharmacokinetic investigations of dandelion in rats for the treatment of diabetes mellitus.

  2025cites this paper
• Proteomic profiling reveals immunomodulatory role of IL-33 in ocular bacterial and fungal infections

  2025cites this paper
• Comparative Tear Fluid Proteomics to Explore Treatment Responsiveness in Diabetic Macular Edema: A Pilot Study

  2025cites this paper
• Vitamin Bs as Potent Anticancer Agents through MMP-2/9 Regulation.

  2025cites this paper
• Applications of Matrix Metalloproteinase-9-Related Nanomedicines in Tumors and Vascular Diseases

  2025cites this paper
• Association of circadian dysregulation with retinal degeneration and Alzheimer’s disease: a special focus on Muller glial cells

  2024cites this paper
• The Role of Antioxidant Plant Extracts’ Composition and Encapsulation in Dietary Supplements and Gemmo-Derivatives, as Safe Adjuvants in Metabolic and Age-Related Conditions: A Review

  2024cites this paper
• Impaired Removal of the Damaged Mitochondria in the Metabolic Memory Phenomenon Associated with Continued Progression of Diabetic Retinopathy

  2023cites this paper
• Bee Honey Extract Attenuates Hyperglycemia in Induced Type 1 Diabetes: Impact of Antioxidant and Angiogenesis Activities on Diabetic Severity In Vivo

  2023cites this paper
• High glucose enhances the activation of NLRP3 inflammasome by ambient fine particulate matter in alveolar macrophages

  2023cites this paper
• The Safety of Pharmacological and Surgical Treatment of Diabetes in Patients with Diabetic Retinopathy—A Review

  2021cites this paper
• Intracerebral Hemorrhage and Diabetes Mellitus: Blood-Brain Barrier Disruption, Pathophysiology, and Cognitive Impairments.

  2021cites this paper
• Diabetes-related intestinal region-specific thickening of ganglionic basement membrane and regionally decreased matrix metalloproteinase 9 expression in myenteric ganglia

  2021cites this paper
• The Role of MMP-9 rs 3918242 genetic variant in association between MMP-9 serum level with risk factors of acute ischemic stroke

  2021cites this paper
• AAV-Mediated Expression of Human VEGF, TNF-α, and IL-6 Induces Retinal Pathology in Mice

  2021cites this paper
• Circulating miRNAs in diabetic retinopathy patients: prognostic markers or pharmacological targets?

  2021cites this paper
• Diabetic Nephropathy – a Review of Risk Factors, Progression, Mechanism, and Dietary Management

  2021cites this paper
• Mechanistic dissection of diabetic retinopathy using the protein-metabolite interactome

  2020cites this paper
• Role of MMP-9 in Diabetic Retinopathy

  2020cites this paper
• Acute changes in the retina and central retinal artery with methamphetamine.

  2020cites this paper
• Subgingival Endotoxin and Lipoteichoic acid modulates cytokine production in diabetics subjects: A Case-control Study.

  2020cites this paper
• Retinoprotection by BGP-15, a Hydroximic Acid Derivative, in a Type II Diabetic Rat Model Compared to Glibenclamide, Metformin, and Pioglitazone

  2020cites this paper
• Homocysteine Disrupts Balance between MMP-9 and Its Tissue Inhibitor in Diabetic Retinopathy: The Role of DNA Methylation

  2020cites this paper
• Differential Renoprotective Actions of Simvastatin and Rosuvastatin in Streptozotocin-Induced Diabetes in Sprague-Dawley Rat

  2020cites this paper
• Immunohistochemical characteristics of MMP-9 and TIMP-1 markers expression in the cerebral cortex in diabetes mellitus type 2

  2020cites this paper
• Diabetes-mediated IL-17A enhances retinal inflammation, oxidative stress, and vascular permeability.

  2019cites this paper
• Targeting Matrix Metalloproteinases for Diabetic Retinopathy: The Way Ahead?

  2019cites this paper
• Statins in ophthalmology.

  2019cites this paper
• Involvement of matrix metalloproteinases in capillary degeneration following NMDA‐induced neurotoxicity in the neonatal rat retina

  2019cites this paper
• Matrix metalloproteinase 9 induces keratinocyte apoptosis through FasL/Fas pathway in diabetic wound

  2019cites this paper
• Can Epigenetics of Endothelial Dysfunction Represent the Key to Precision Medicine in Type 2 Diabetes Mellitus?

  2019cites this paper
• Matrix metalloprotease-9 polymorphism and its association with Atherosclerosis - A case-control study in Pakistani population.

  2019cites this paper
• Cysteine-based regulation of redox-sensitive Ras small GTPases

  2019cites this paper
• Poly(lactic-co-glycolic acid) nanoparticle-mediated interleukin-12 delivery for the treatment of diabetic retinopathy

  2019cites this paper
• Agonist-Biased Signaling via Matrix Metalloproteinase-9 Promotes Extracellular Matrix Remodeling

  2018cites this paper
• Proliferative Diabetic Retinopathy: An Overview of Vitreous Immune and Biomarkers

  2018cites this paper
• Alterations in the polysialylated neural cell adhesion molecule and retinal ganglion cell density in mice with diabetic retinopathy.

  2018cites this paper
• Identification of new candidate genes for retinopathy in type 2 diabetics. Valencia Study on Diabetic Retinopathy (VSDR). Report number 3.

  2018cites this paper
• IGF-1R Regulates the Extracellular Level of Active MMP-2, Pathological Neovascularization, and Functionality in Retinas of OIR Mouse Model

  2018cites this paper
• Identification of new candidate genes for retinopathy in type 2 diabetics. Valencia Study on Diabetic Retinopathy (VSDR). Report number 3.

  2018cites this paper
• Circulating matrix modulators (MMP-9 and TIMP-1) and their association with severity of diabetic retinopathy.

  2018cites this paper
• Estimation of ellagic acid and/or repaglinide effects on insulin signaling, oxidative stress, and inflammatory mediators of liver, pancreas, adipose tissue, and brain in insulin resistant/type 2 diabetic rats.

  2017cites this paper
• Antioxidative Effects of Rhodiola Genus: Phytochemistry and Pharmacological Mechanisms against the Diseases.

  2017cites this paper
• Oxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy

  2017cites this paper
• Retinal pigment epithelium-secretome: A diabetic retinopathy perspective.

  2017cites this paper
• In vitro studies on nobiletin isolated from citrus plants and the bioactive metabolites, inhibitory action against gelatinase enzymatic activity and the molecular mechanisms in human retinal Müller cell line.

  2017cites this paper
• Smoking and Eye Pathologies. A Systemic Review. Part II. Retina Diseases, Uveitis, Optic Neuropathies, Thyroid-Associated Orbitopathy.

  2017cites this paper
• Diabetic retinopathy, metabolic memory and epigenetic modifications.

  2017cites this paper
• Extracellular matrix remodeling and vascular complications in type1 diabetes

  2017cites this paper
• Crosstalk Between Histone and DNA Methylation in Regulation of Retinal Matrix Metalloproteinase-9 in Diabetes

  2017cites this paper
• Regulation of Matrix Metalloproteinase in the Pathogenesis of Diabetic Retinopathy.

  2017cites this paper
• Role of PARP-1 as a novel transcriptional regulator of MMP-9 in diabetic retinopathy.

  2017cites this paper
• Molecular Mechanism of Transcriptional Regulation of Matrix Metalloproteinase‐9 in Diabetic Retinopathy

  2016cites this paper
• Association of potential salivary biomarkers with diabetic retinopathy and its severity in type-2 diabetes mellitus: a proteomic analysis by mass spectrometry

  2016cites this paper
• Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients

  2016cites this paper
• High-mobility group box-1 regulates the expression of matrix metalloproteinase-9 in diabetic retina

  2016cites this paper
• Role of matrix metalloproteinase 9 and its tissue inhibitor 1 in development and prognosis of diabetic retinopathy.

  2016cites this paper
• Inhibition of Matrix Metalloproteinase 9 Enhances Rod Survival in the S334ter-line3 Retinitis Pigmentosa Model

  2016cites this paper
• Expression Profiling of Genes Related to Endothelial Cells Biology in Patients with Type 2 Diabetes and Patients with Prediabetes

  2016cites this paper
• Effect of the herbal mixture composed of Aloe Vera, Henna, Adiantum capillus-veneris, and Myrrha on wound healing in streptozotocin-induced diabetic rats

  2016cites this paper
• 8-iso-prostaglandin-F2α: a possible trigger or accelerator of diabetic retinopathy.

  2016cites this paper
• Current concepts regarding developmental mechanisms in diabetic retinopathy in Taiwan

  2016cites this paper
• Epigenetic Modification of Mitochondrial DNA in the Development of Diabetic Retinopathy.

  2015cites this paper
• Association of endothelin-1 and matrix metallopeptidase-9 with metabolic syndrome in middle-aged and older adults

  2015cites this paper
• Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy.

  2015influential citation
• Tiam1-Rac1 Axis Promotes Activation of p38 MAP Kinase in the Development of Diabetic Retinopathy: Evidence for a Requisite Role for Protein Palmitoylation

  2015cites this paper
• Apoptotic effect of mtrix metalloproteinases 9 in the development of diabetic retinopathy.

  2015cites this paper
• Matrix Metalloproteinase-9 in the Culprit Coronary Artery and Myocardial No-Reflow

  2015cites this paper
• Contribution of epigenetics in diabetic retinopathy

  2015cites this paper
• The Potential Roles of Superoxide Dismutase, Matrix-Metalloprotinase-9 and Interlukine -18 with the Prevalence and Progression of Type II Diabetes Mellitus

  2015cites this paper
• Protective Role of Ginger on the Induced Diabetic Retinopathy in Adult Albino Rats

  2014cites this paper
• Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy.

  2014cites this paper
• The adjuvant effect of hypertension upon diabetic peripheral neuropathy in experimental type 2 diabetes.

  2014cites this paper
• Low intravitreal angiopoietin‐2 and VEGF levels in vitrectomized diabetic patients with simvastatin treatment

  2014cites this paper
• Hyperglycemia Induces Altered Expressions of Angiogenesis Associated Molecules in the Trophoblast

  2013cites this paper
• Protective and anti-angiopathy effects of caffeic acid phenethyl ester against induced type 1 diabetes in vivo.

  2013cites this paper
• Regulation of matrix metallopeptidase-9 by epigenetic modifications, and the development of diabetic retinopathy modifications of in

  2013influential citation
• Interrelationship between activation of matrix metalloproteinases and mitochondrial dysfunction in the development of diabetic retinopathy.

  2013cites this paper
• Metabolic Syndrome and Inflammation: A Critical Review of In Vitro and Clinical Approaches for Benefit Assessment of Plant Food Supplements

  2013cites this paper
• VEGF Secreted by Hypoxic Müller Cells Induces MMP-2 Expression and Activity in Endothelial Cells to Promote Retinal Neovascularization in Proliferative Diabetic Retinopathy

  2013cites this paper
• Diabetes-Induced Superoxide Anion and Breakdown of the Blood-Retinal Barrier: Role of the VEGF/uPAR Pathway

  2013cites this paper
• Regulation of Matrix Metalloproteinase-9 by Epigenetic Modifications and the Development of Diabetic Retinopathy

  2013cites this paper
• Ang‐2 upregulation correlates with increased levels of MMP‐9, VEGF, EPO and TGFβ1 in diabetic eyes undergoing vitrectomy

  2013cites this paper
• Epigenetic Modifications and Diabetic Retinopathy

  2013cites this paper
• The ERK1/2 Inhibitor U0126 Attenuates Diabetes-Induced Upregulation of MMP-9 and Biomarkers of Inflammation in the Retina

  2013cites this paper
• Diabetic retinopathy and signaling mechanism for activation of matrix metalloproteinase‐9

  2012cites this paper
• Role of matrix metalloproteinase-2 and -9 in the development of diabetic retinopathy

  2012cites this paper
• Inhibition of connective tissue growth factor by small interfering ribonucleic acid prevents increase in extracellular matrix molecules in a rodent model of diabetic retinopathy

  2012cites this paper
• Matrix metalloproteinase-9 and -2 enhance the ligand sensitivity of photoreceptor cyclic nucleotide-gated channels

  2012cites this paper
• Macrophage Metalloelastase (MMP-12) Deficiency Mitigates Retinal Inflammation and Pathological Angiogenesis in Ischemic Retinopathy

  2012cites this paper
• Abrogation of MMP-9 Gene Protects Against the Development of Retinopathy in Diabetic Mice by Preventing Mitochondrial Damage

  2011influential citation
• The α7-nicotinic acetylcholine receptor and MMP-2/-9 pathway mediate the proangiogenic effect of nicotine in human retinal endothelial cells.

  2011cites this paper
• Bone Healing in Diabetes Mellitus Associated Hyperglycemia

  2011cites this paper
• Statins for prevention of diabetic-related blindness: a new treatment option?

  2011cites this paper
• Diabetic retinopathy, superoxide damage and antioxidants.

  2011cites this paper
• Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenon

  2010cites this paper
• α-Glucosidase Inhibitors from Polyscias serrata Roots in a Parallel Study of Network Pharmacology

  year unknowncites this paper